Loading...

Sona Nanotech Inc.

SNANFPNK
Healthcare
Medical - Diagnostics & Research
$0.35
$-0.02(-6.38%)

Sona Nanotech Inc. (SNANF) Company Profile & Overview

Explore Sona Nanotech Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Sona Nanotech Inc. (SNANF) Company Profile & Overview

Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEODavid Andrew Regan

Contact Information

902-442-0653
Purdy’s Wharf Tower II, Halifax, NS, B3J 3R7

Company Facts

8 Employees
IPO DateJul 27, 2006
CountryCA
Actively Trading

Frequently Asked Questions

;